Skip to main content

Tagged With "Puriton Eye Relief Drops"

Survey

Understanding Asthma Treatments

AAFA Community Services ·
Please watch this video and answer the following questions. Your responses are anonymous. By answering these questions, you are participating in asthma research! A proper treatment plan created by you and your doctor can help you manage your asthma. This can include medicines, avoiding triggers and following an Asthma Action Plan. Discover types of asthma medicines used to treat asthma and how your involvement in research can improve asthma treatment. Watch video on YouTube Watch the next...
Blog Post

2016 Spring Allergy Capitals Report Ranks The Most Challenging Cities Nationwide For Allergies

AAFA Community Services ·
Today, the Asthma and Allergy Foundation of America (AAFA), a leading patient advocacy organization in the United States representing nearly 61 million Americans who experience asthma or allergies, released its annual Spring Allergy Capitals™ report. The report identifies the 100 most challenging places to live with spring allergies in the U.S. Jackson, MS is the most challenging U.S. city to live for the second year in a row based on higher than average pollen scores, higher than average...
Blog Post Featured

2018 Fall Allergy Capitals Report: Is Your City on Our List?

AAFA Community Services ·
Ragweed and other fall allergens are found throughout the U.S., but some areas feel the effects more than others. The Asthma and Allergy Foundation of America (AAFA) has released the 2018 Fall Allergy Capitals™ report.
Blog Post Featured

2018 Spring Allergies Capitals Report: How Does Your City Rank?

AAFA Community Services ·
As many in the U.S. put away their winter coats, they pull out the allergy medicines. The onslaught of pollen that comes each spring affects millions of Americans with seasonal allergies. The Asthma and Allergy Foundation of America (AAFA) has released the 2018 Spring Allergy Capitals™ report that ranks the top 100 cities in the nation for spring allergies
Blog Post Featured

2019 Spring Allergy Capitals: See If Your City Made Our List

AAFA Community Services ·
The Asthma and Allergy Foundation of America (AAFA) has released the 2019 Spring Allergy Capitals™ report to look at why some locations are more affected than others. Our report ranks the top 100 cities in the nation for spring allergies.
Blog Post

3 New Studies Shed Light on Penicillin Allergy

AAFA Community Services ·
At some point you may have had a reaction to penicillin and were told you were allergic. And there’s a good chance it has stayed in your chart throughout your childhood and into adulthood. But 9 of 10 Americans who think they have a penicillin allergy have either outgrown it or never had it in the first place. That said, it’s important to get tested by an allergist to know if you have a true penicillin allergy so you know whether to avoid the drug.
Blog Post

4 Things You Must Know About the Flu If You Have Asthma

AAFA Community Services ·
Flu season is here and already making headlines. During the 2017-2018 flu season, it is estimated that more than 80,000 people died from the flu or flu complications . More than 900,000 were hospitalized. These numbers are the highest we've seen in decades. Everyone needs to take steps to protect themselves for this flu season now before it peaks, especially people with asthma . As you prepare to deal with co-workers who come to work sick, kids who bring illnesses home from school or germy...
Blog Post

5 Things You May Not Know About Ragweed Pollen Allergy

AAFA Community Services ·
If you live in the U.S., you’re probably starting to feel the effects of ragweed pollen. Ragweed pollen allergy affects about 25 million Americans, making it one of the most common weed allergy. Its light pollen easily spreads far and wide, causing people with nasal and allergic asthma symptoms to feel miserable each fall.
Blog Post

AAFA Elevates Patient Voice in ICER Review of New Peanut Allergy Treatments

AAFA Community Services ·
On June 11, 2019, in Oakland, California, the Institute for Clinical and Economic Review (ICER) and its California Technology Assessment Forum (CTAF) met to assess the clinical effectiveness and value of treatments for peanut allergy. The review examined two new technologies to induce immune tolerance — Viaskin® Peanut (DBV Technologies) and AR101 (Aimmune Therapeutics) — as well as non-commercialized oral immunotherapy (OIT).
Blog Post

AAFA Explains: What Is the Difference Between Alternative and Complementary Medicine?

AAFA Community Services ·
What is the difference between alternative, complementary and integrative medicine? The Asthma and Allergy Foundation of America (AAFA) wants you to know what these mean so that you can make informed healthcare choices. Complementary medicine refers to something you do or take along with treatment your doctor tells you to follow. Alternative medicine refers to something you do or take instead of your regular treatment. Integrative health care is the practice of combining complementary and...
Blog Post Featured

AAFA Names 15 States to 2016 State Honor Roll™ of Asthma and Allergy Policies for Schools

AAFA Community Services ·
The 2016 State Honor Roll™ of Asthma and Allergy Policies for Schools (SHR) report identifies states that make it a priority to create healthy school settings for students with asthma and allergies. This annual report lists states with comprehensive laws and policies aimed at keeping children with asthma and allergies healthy at school.
Blog Post

AAFA Study Highlights Negative Impact Eczema Can Have on Quality of Life

AAFA Community Services ·
If you’ve never suffered from eczema, also known as atopic dermatitis, you probably aren’t aware of the negative impact it can have on quality of life. The severe itching, redness and excessively dry skin all make life miserable for those who suffer from the allergic disease.
Blog Post Featured

AAFA Study Shows Surprising Rate and Severity of Atopic Dermatitis in Adults

AAFA Community Services ·
The Asthma and Allergy Foundation of America (AAFA) led a research study called Atopic Dermatitis in America . The purpose of this study is to shed light on the number of adults who deal with this frustrating skin condition. This week, AAFA has released early findings from the report. One surprising find from the study was the number of adults with AD who say it is moderate to severe. As many as 40% of the people surveyed said they had moderate-to-severe AD. Through this study, we hope to...
Blog Post

Act Now to Help Save Health Care Protections for Those With Asthma and Allergies

AAFA Community Services ·
On Sept. 13, 2017, Senators Lindsey Graham (R-SC) and Bill Cassidy (R-LA) introduced a new bill to repeal the Affordable Care Act (ACA). The ACA includes protections for those with pre-existing conditions. Their goal is to vote on the repeal before Sept. 30, 2017. This bill, commonly called the Graham-Cassidy bill, could cause millions of Americans to lose health insurance. If passed, health insurance could become unaffordable for people with chronic conditions and low incomes.
Blog Post

Air Pollution Causes Asthma Symptoms for One Hartford Resident

AAFA Community Services ·
Lakia Shavon Lightner has vivid memories from her childhood of visits to the emergency room at 2 in the morning. She has had severe asthma and allergies for as long as she can remember. She grew up in Hartford, but now lives in East Hartford, Connecticut, our #13 Asthma Capital for 2019.
Blog Post

Albuterol Inhaler Shortage Due to COVID-19 Could Impact People With Asthma

AAFA Community Services ·
The Asthma and Allergy Foundation of America is sharing this message from the American College of Allergy, Asthma and Immunology (ACAAI)for people with asthma about a shortage of albuterol metered dose inhalers
Blog Post

Asthma and Allergy Caucus to FDA: Take Action to Prevent Albuterol Shortages

AAFA Community Services ·
Congressmen Eliot L. Engel (D-NY) and Fred Upton (R-MI), Co-Chairs of the Asthma and Allergy Caucus, joined by Congressmen TJ Cox (D-CA) and Peter King (R-NY), Members of Caucus, led 57 Members of the House on a letter to the Food and Drug Administration (FDA) about shortages of albuterol inhalers, which are critical to effective asthma management.
Blog Post

Asthma and Allergy Research Review January-March 2017

AAFA Community Services ·
The Asthma and Allergy Foundation of America will recap some of the top research about allergies and asthma every three months. Here is a look at studies reported between January and March. Read about how treating homes for cockroaches can improve children's asthma, a possible link between insomnia and developing asthma, the safety of allergy immunotherapy and more.
Blog Post

Asthma and Allergy To-Do List Before School Ends for Summer Break

AAFA Community Services ·
Around the U.S., the school year is almost over! If you have a child with asthma or allergies, add these to your end-of-year to-do list.
Blog Post

Asthma Drug Shortages During COVID-19: A Letter From AAFA’s President and CEO

AAFA Community Services ·
Because of the COVID-19 (new coronavirus) pandemic, we are facing a challenging and unprecedented time. COVID-19 is a respiratory infection, and the nearly 25 million Americans with asthma are at high risk for complications from the virus. As the leading patient organization for people with asthma and allergies, this has the Asthma and Allergy Foundation of America (AAFA) deeply concerned for your health and well-being.
Blog Post

Medication Recall Alert: Puriton Eye Relief Drops Due to Non-Sterile Production Conditions

AAFA Community Services ·
Kadesh Incorporation Issues Voluntary Nationwide Recall of Puriton Eye Relief Drops Due to Non-Sterile Production Conditions For Immediate Release November 7, 2018 Contact Consumers Recall Department contact@puriton.us Announcement Kadesh, Inc. of Garden Grove, CA is voluntarily recalling all lots of Puriton Eye Relief Drops, 0.5 oz. (15ml) bottle, UPC 7 36972 1679 0, to the consumer level. During a recent FDA inspection, investigators observed that ophthalmic drugs, which are required to be...
Blog Post

Atopic Dermatitis in America: Find Relief for This Painful Itchy Rash

AAFA Community Services ·
If you have atopic dermatitis (AD) , you know a dry, itchy, red rash on your hands, arms, legs or other parts of the body is a part of daily life. AD is an allergic condition and the most common type of eczema. More than 18 million Americans of all ages have AD. The severity of AD can be different for each person and does not depend on when you developed the disease. However, AAFA’s recent study titled Atopic Dermatitis in America found that people with adult- and late childhood-onset AD...
Blog Post

Attack Asthma Run Raises Awareness and Money for Asthma

AAFA Community Services ·
Nearly 25 million Americans have asthma. This includes more than 400 students at San Leandro High School in California. When Jan Othen, a health and physical education teacher, learned how many students at her school have asthma and she heard about several asthma-related deaths, she decided she had to do something to help raise awareness.
Blog Post

Babies With A Dog in the Home May Have a Lower Risk of Asthma and Eczema

AAFA Community Services ·
Two studies being presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting show there may be even more reason to love your dog.
Blog Post

Back-to-School: Students and Asthma Inhalers

AAFA Community Services ·
Did you know your state allows students to self-carry a quick-relief asthma inhaler while at school? Every state has a policy that allows students in public schools to self-carry, although each has its own procedures. This applies to every state in the U.S. Now is the time of year to get your school forms signed by your child's doctor. These forms include your child's asthma action plan and medication authorization form. Asthma is the leading cause of school absences due to a chronic...
Blog Post

Bedroom Hygiene Is Crucial for Healthy Sleep Hygiene

AAFA Community Services ·
Frequent sleep disturbances and daytime sleepiness are the most telling signs of poor sleep hygiene according to the National Sleep Foundation. Sleep disturbances are commonly reported by people with asthma, eczema and allergies.
Blog Post

Bill Introduced to Encourage Schools to Stock Quick-Relief Asthma Medicines

AAFA Community Services ·
The School-Based Respiratory Health Management Act, H.R. 2285, was filed on May 2, 2017, in the U.S. House of Representatives. This bill would require states to also have laws that allow schools to keep asthma quick-relief medicines on hand. Learn more about this bill and how to get involved.
Blog Post

Breathing in the Boat: It Was All Worth It

Megan Roberts ·
On Oct. 14, 2017, I began my travel across the world to compete at the 13th International Dragon Boat Federation’s Nations World Championships on Dianchi Lake in Kunming, China, after a long and unlikely journey to overcome asthma symptoms that nearly prevented me from competing at all.
Blog Post

Breathing Wildfire Smoke Puts Kids and People at Risk

AAFA Community Services ·
As the California wildfires rage, the San Francisco Bay Area is seeing some of the worst air quality ever recorded in the area. If you are in the affected area, take precautions to protect you and your family from the poor air quality . Smoke in the air can contain tiny particles that can get into your lungs and irritate your eyes, nose, throat and lungs. Poor air quality can worsen asthma symptoms . Children and those with respiratory disease are at high risk for asthma episodes when the...
Blog Post

Children Who Do Not Have Access to Fresh Fruits and Veggies Have Higher Rates of Asthma

AAFA Community Services ·
Living in a food desert – an urban area where it is difficult to buy affordable or good-quality fresh food – means you’re at increased risk to have asthma. Children who were studied who did not have access to fresh fruits and vegetables had higher rates of asthma than children who did have access.
Blog Post

Cold Weather Advisory: People With Asthma Should Take Precautions to Avoid Symptoms

AAFA Community Services ·
As we gear up (and bundle up) for the holiday season, people with asthma who live in cold climates may notice they are having a tougher time breathing. That’s because when you breathe in dry, cold air, your airways start to narrow, making it hard to breathe. Fortunately, there are a few things you can do to reduce asthma triggers and the chance of having asthma symptoms or an attack this winter season.
Blog Post

Congress Introduces Bill to Protect Students with Asthma

AAFA Community Services ·
Congress is taking steps to improve how schools across the country manage asthma. The federal bill is called the School-Based Asthma Management Programs Act (HR 4662). The bill encourages states to improve asthma care in schools. Schools that adopt improved asthma management programs and policies would have a better chance of receiving federal grant money for asthma programs. Representatives Phil Roe (R-TN) and Steny Hoyer (D-MD) are the sponsors of the bill. The bill calls for: stocking...
Blog Post

COVID-19 and Its Impact on People With Asthma and Allergies: A Global Health Crisis

AAFA Community Services ·
The Asthma and Allergy Foundation of America (AAFA) has been fighting to save lives for nearly 70 years. With your support, we provide education, conduct patient-centered research and advocate for protections for our community. Our experience and strong community ties allowed us to take prompt action on the COVID-19 crisis . Thanks to your generous support, we are leading the fight against COVID-19 for people with asthma and allergies. But we need your help to continue to provide COVID-19...
Blog Post

Creating an Asthma Management Plan in Philadelphia, Pennsylvania, the #4 Asthma Capital

AAFA Community Services ·
When Joey was 4 years old, his parents took him to see an allergist. He was having trouble breathing and having challenges with his digestive system. They learned that Joey has asthma triggered by environmental and food allergies.
Blog Post

CVS Sinus Relief Nasal Mist Recalled Due to Contamination

AAFA Community Services ·
Holly Hill, FL, Product Quest Manufacturing (“Product Quest”) is voluntarily recalling Lot# 173089J of CVS Health 12 Hour Sinus Relief Nasal Mist, a clear, colorless liquid, to the consumer level. The product was found to have had microbiological contamination identified as Pseudomonas aeruginosa.
Blog Post

Does Your School Stock Medicine for Asthma Emergencies?

AAFA Community Services ·
Does your state allow schools to stock quick-relief medicines for asthma? Quick-relief medicines , such as albuterol, act fast to relax tight muscles around your airways. This allows the airways to open up so air can flow through them. Congress is considering a law to encourage states to permit these “ albuterol stocking ” school policies . The School-Based Asthma Management Programs Act builds upon a similar law that encourages states to require schools to stock epinephrine auto-injectors.
Blog Post

Dupixent® Shows Positive Results in Phase 3 of Trial for Ages 6 to 11 With Severe Atopic Dermatitis

AAFA Community Services ·
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that a pivotal Phase 3 trial evaluating Dupixent® (dupilumab) to treat severe atopic dermatitis in children aged 6 to 11 years met its primary and secondary endpoints. Dupixent is the first and only biologic to show positive results in this pediatric atopic dermatitis population.
Blog Post

Family Removed from Plane After Boy’s Allergic Reaction to Dog

AAFA Community Services ·
Be kind. Be nice. That is the message that a father with terminal cancer gives when he and his family are removed from a plane after his young son has an allergic reaction to a dog.
Blog Post

FDA Approves Dupixent® for Treatment of Asthma

AAFA Community Services ·
The FDA has approved another biologic treatment, Dupixent, for the treatment of both moderate and severe asthma patients with eosinophilic phenotype and oral corticosteroid-dependent asthma, regardless of phenotype.
Blog Post

FDA Approves FASENRA® Pre-Filled Auto-Injector Pen for Self-Administration

AAFA Community Services ·
AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved the self-administration of FASENRA® (benralizumab) in a pre-filled, single-use auto-injector (the FASENRA Pen™).
Blog Post

FDA Approves Generic of Proventil HFA Albuterol Inhaler to Meet Demand Due to COVID-19

AAFA Community Services ·
The U.S. Food and Drug Administration today approved the first generic of Proventil HFA (albuterol sulfate) Metered Dose Inhaler, 90 mcg/Inhalation, for the treatment or prevention of bronchospasm in patients four years of age and older who have reversible obstructive airway disease, as well as the prevention of exercise-induced bronchospasm in this age group.
Blog Post

FDA Approves ProAir HFA Generic, a Quick-Relief Medicine for Asthma

AAFA Community Services ·
The U.S. Food and Drug Administration today approved the first generic of ProAir HFA (albuterol sulfate) Inhalation Aerosol for the treatment or prevention of bronchospasm in patients four years of age and older with reversible obstructive airway disease and the prevention of exercise-induced bronchospasm in patients four years of age and older.
Blog Post

FDA Approves Symbicort to Treat Asthma In Children Ages 6-12

AAFA Community Services ·
AstraZeneca announced that the US Food and Drug Administration (FDA) approved SYMBICORT® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol 80/4.5 micrograms for the treatment of asthma in pediatric patients aged six up to 12 years.
Blog Post

FDA Approves Two New Asthma Inhalers

AAFA Community Services ·
[Press Release] Teva Announces FDA Approval of Two New RespiClick® Maintenance Inhalers for the Treatment of Asthma Approvals Expand Portfolio of Respiratory Medicines Delivered in RespiClick® Inhaler Designed to Eliminate the Need for Hand-Breath Coordination During Inhalation JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) announced that the U.S. Food and Drug Administration (FDA) approved two products for adolescent and adult patients with asthma.
Blog Post

Fighting for Air in Detroit, Michigan, the #16 Asthma Capital

AAFA Community Services ·
Shari Duncan has had asthma for more than three decades. In recent years it has become quite severe. Shari takes daily asthma maintenance medicines, does nebulizer breathing treatments and works hard to avoid her biggest asthma triggers. She also uses her quick-relief inhaler about once or twice a week. In spite of these efforts, four to six times a year Shari is hospitalized for asthma.
Blog Post

First Grader with Severe Asthma Runs Marathon One Step at a Time

AAFA Community Services ·
Luke Bilbo has severe asthma. But he also has a lot of determination. Enough determination to run a marathon. In Luke’s seven short years, he’s already been in the hospital more times than anyone can count. In kindergarten, he missed 54 days of school. When he did go to school, he had to wear a mask to protect him from germs and asthma triggers . He also had a spot on his lungs that only went away after a long treatment. The last thing his mother, Amanda Bilbo, thought he would do is run...
Blog Post Featured

For People With Asthma, the Danger of “Peak Week” Is Here

AAFA Community Services ·
Peter DeMarco of Boston, Massachusetts, lost his wife, Laura Levis, to asthma during Asthma Peak Week in 2016. In the essay below, Peter shares Laura's story, as well as some facts about Asthma Peak Week. If you have asthma, taking precautions can help prevent asthma episodes, attacks and hospitalizations in September.
Blog Post

GlaxoSmithKline Study Shows Nucala Improves Quality of Life, Lung Function in Severe Asthma

AAFA Community Services ·
GlaxoSmithKline plc (LSE/NYSE:GSK) today announced data demonstrating that severe asthma patients, whose disease is driven by eosinophilic inflammation, treated with first-in-class biologic Nucala® (mepolizumab) added-on to standard of care, achieved clinically and statistically significant improvements in their health-related quality of life and lung function, when compared to patients treated with placebo and standard of care. These results are from the phase IIIb MUSCA study (NCT02281318, 200
Blog Post

GSK to Offer Generic Version of Ventolin HFA Albuterol Inhaler

AAFA Community Services ·
The Asthma and Allergy Foundation of America is sharing this press release from GlaxoSmithKline to bring you the latest research news quickly. [PRESS RELEASE] GSK announces availability of Authorized Generic Albuterol Sulfate Inhaler for treatment or prevention of bronchospasm Effective, January 15, 2019, GSK announced the availability of an authorized generic (AG) of Ventolin HFA (albuterol sulfate) inhalation aerosol. The AG will be manufactured by GSK and distributed by Prasco LLC. The...
Blog Post Featured

Help Shape the Future of Asthma Treatment

AAFA Community Services ·
Share your thoughts on the future of asthma treatment. Take two short surveys by Jan. 12, 2020, 11:59 p.m. ET, and we'll submit your responses to be considered for updates to the Guidelines for the Diagnosis and Management of Asthma.
 
×
×
×
×